Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Staaf

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Ebiomedicine|March 6, 2024
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studiesBenedetta Conte, Fara Brasó-Maristany, Adela Rodríguez Hernández, et al.
Nature Communications|March 17, 2017
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitriesSilvia Grasso, Jennifer Chapelle, Vincenzo Salemme, et al.
Nature Communications|March 31, 2018
Author Correction: The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitriesSilvia Grasso, Jennifer Chapelle, Vincenzo Salemme, et al.
Nature Cancer|December 6, 2021
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanismsJanne Lehtiö, Taner Arslan, Ioannis Siavelis, et al.
The Lancet. Oncology|October 10, 2025
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysisDaniella Black, Helen Ruth Davies, Gene Ching Chiek Koh, et al.
Nature Communications|April 17, 2019
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylationArie B Brinkman, Serena Nik-Zainal, Femke Simmer, et al.
Nature Genetics|January 24, 2017
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancersDominik Glodzik, Sandro Morganella, Helen Davies, et al.
Nature Genetics|October 28, 2017
Corrigendum: A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancersDominik Glodzik, Sandro Morganella, Helen Davies, et al.
Nature Communications|May 19, 2026
High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunitiesLucia Chmelova, Helen R Davies, Andrea Degasperi, et al.
Nature Medicine|March 14, 2017
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signaturesHelen Davies, Dominik Glodzik, Sandro Morganella, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Ebiomedicine|March 6, 2024
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studiesBenedetta Conte, Fara Brasó-Maristany, Adela Rodríguez Hernández, et al.
Nature Communications|March 17, 2017
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitriesSilvia Grasso, Jennifer Chapelle, Vincenzo Salemme, et al.
Nature Communications|March 31, 2018
Author Correction: The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitriesSilvia Grasso, Jennifer Chapelle, Vincenzo Salemme, et al.
Nature Cancer|December 6, 2021
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanismsJanne Lehtiö, Taner Arslan, Ioannis Siavelis, et al.
The Lancet. Oncology|October 10, 2025
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysisDaniella Black, Helen Ruth Davies, Gene Ching Chiek Koh, et al.
Nature Communications|April 17, 2019
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylationArie B Brinkman, Serena Nik-Zainal, Femke Simmer, et al.
Nature Genetics|January 24, 2017
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancersDominik Glodzik, Sandro Morganella, Helen Davies, et al.
Nature Genetics|October 28, 2017
Corrigendum: A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancersDominik Glodzik, Sandro Morganella, Helen Davies, et al.
Nature Communications|May 19, 2026
High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunitiesLucia Chmelova, Helen R Davies, Andrea Degasperi, et al.
Nature Medicine|March 14, 2017
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signaturesHelen Davies, Dominik Glodzik, Sandro Morganella, et al.
Pageof 18